Verastem outlines cash runway into the first half of 2027 while targeting LGSOC self-sustainability in the second half of 2026
Source: SeekingAlpha
2026-05-07 23:43:02 ET
More on Verastem
- Verastem, Inc. (VSTM) Q1 2026 Earnings Call Transcript
- Vectoring In On Verastem
- Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play
- Verastem Non-GAAP EPS of -$0.43 beats by $0.04, revenue of $18.67M misses by $2.72M
- Verastem Q1 2026 Earnings Preview
Read the full article on Seeking Alpha
For further details see:
Verastem outlines cash runway into the first half of 2027 while targeting LGSOC self-sustainability in the second half of 2026
Verastem Inc.
NASDAQ: VSTM
VSTM Trading
4.84% G/L:
$3.90 Last:
2,423,775 Volume:
$3.76 Open:
VSTM Latest News
VSTM Stock Data
$424,027,638
66,108,246
1.4%
15
N/A
Biotechnology & Life Sciences
Healthcare
US
Needham
